Enhancing Prospective Thinking in Early Recovery

The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering stimulant use disorder (SUD) persons. The main question\[s\] this trial aims to answer are: Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.

Inclusion Criteria: * Abstinence between ≥14 days and ≤1 year * At least 18 years old * Verbal endorsement of commitment to recovery * Outpatient * Psychotropic drugs for SUD-comorbidity * Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit * English comprehension Exclusion Criteria: * Unstable medical disorders * Less than 18 years old * Habitual drug use * Mu-opioid drugs * Smell/taste disorders * Unstable psychiatric conditions * Extravagant/elaborate face tattoos